Home
ENGN
ENGN News

Latest enGene Holdings Inc. (ENGN) News on July 1, 2025

MT Newswires

6 days ago

enGene Receives RMAT Designation From US FDA for Bladder Cancer Therapy

FDA Grants RMAT Designation for enGene’s Detalimogene, Enabling Potential for Expedited Review in High-Risk, Non-Muscle Invasive Bladder Cancer

Business Wire

6 days ago

FDA Grants RMAT Designation for enGene’s Detalimogene, Enabling Potential for Expedited Review in High-Risk, Non-Muscle Invasive Bladder Cancer

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

14 days ago

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

enGene Reports Second Quarter 2025 Financial Results and Provides Business Update

Business Wire

19 days ago

enGene Reports Second Quarter 2025 Financial Results and Provides Business Update

enGene Announces the Resignation of its Chief Medical Officer

Business Wire

a month ago

enGene Announces the Resignation of its Chief Medical Officer

enGene to Present at the Jefferies Global Healthcare Conference

Business Wire

a month ago

enGene to Present at the Jefferies Global Healthcare Conference

enGene Names Amy Pott as Chief Global Commercialization Officer

Business Wire

a month ago

enGene Names Amy Pott as Chief Global Commercialization Officer

enGene to Participate in Upcoming Investor Conferences

Business Wire

2 months ago

enGene to Participate in Upcoming Investor Conferences

enGene Holdings Inc.'s (NASDAQ:ENGN) largest shareholders are private equity firms with 38% ownership, institutions own 35%

Simply Wall St.

2 months ago

enGene Holdings Inc.'s (NASDAQ:ENGN) largest shareholders are private equity firms with 38% ownership, institutions own 35%

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

3 months ago

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

enGene to Present at the Stifel 2025 Virtual Targeted Oncology Forum

Business Wire

3 months ago

enGene to Present at the Stifel 2025 Virtual Targeted Oncology Forum

enGene Holdings Insider Ups Holding During Year

Simply Wall St.

4 months ago

enGene Holdings Insider Ups Holding During Year

enGene Reports First Quarter 2025 Financial Results and Provides Business Update

Business Wire

4 months ago

enGene Reports First Quarter 2025 Financial Results and Provides Business Update

enGene to Participate in the Leerink Partners Global Healthcare Conference

Business Wire

4 months ago

enGene to Participate in the Leerink Partners Global Healthcare Conference

enGene to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Business Wire

5 months ago

enGene to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

5 months ago

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

enGene to Present Three Posters at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) Highlighting the Ongoing Clinical Development of Detalimogene Voraplasmid for the Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC)

Business Wire

5 months ago

enGene to Present Three Posters at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) Highlighting the Ongoing Clinical Development of Detalimogene Voraplasmid for the Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC)

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

6 months ago

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 12/27/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 12/26/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 12/24/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 12/23/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 12/20/2024

enGene Reports Full Year 2024 Financial Results and Provides a Business Update

Business Wire

6 months ago

enGene Reports Full Year 2024 Financial Results and Provides a Business Update

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 12/19/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 12/18/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 12/17/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 12/16/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 12/13/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 12/12/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 12/11/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 12/10/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 12/09/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 12/06/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 12/05/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 12/04/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 12/03/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 12/02/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 11/29/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 11/27/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 11/26/2024

enGene to Participate in Upcoming Investor Conferences

Business Wire

7 months ago

enGene to Participate in Upcoming Investor Conferences

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 11/25/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 11/22/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 11/21/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 11/20/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 11/19/2024

Argus Research

7 months ago

Daily – Vickers Top Insider Picks for 11/18/2024

With 52% ownership of the shares, enGene Holdings Inc. (NASDAQ:ENGN) is heavily dominated by institutional owners

Simply Wall St.

7 months ago

With 52% ownership of the shares, enGene Holdings Inc. (NASDAQ:ENGN) is heavily dominated by institutional owners

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 11/15/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 11/14/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 11/13/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 11/11/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 11/08/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 11/07/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 11/06/2024

enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

Business Wire

8 months ago

enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 11/05/2024

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 11/04/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 11/04/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 11/01/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 10/31/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 10/30/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 10/29/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 10/28/2024

enGene Announces $60 Million Private Placement Financing

Business Wire

8 months ago

enGene Announces $60 Million Private Placement Financing

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 10/25/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 10/24/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 10/23/2024

enGene Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

8 months ago

enGene Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 10/22/2024

enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer

Business Wire

8 months ago

enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 10/21/2024

Argus Research

8 months ago

Daily – Vickers Top Insider Picks for 10/21/2024

Insider Buys Additional US$57k In enGene Holdings Stock

Simply Wall St.

9 months ago

Insider Buys Additional US$57k In enGene Holdings Stock

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

9 months ago

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort

Business Wire

9 months ago

Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort

enGene Reports Third Quarter 2024 Financial Results and Provides a Business Update

Business Wire

10 months ago

enGene Reports Third Quarter 2024 Financial Results and Provides a Business Update

enGene to Participate in Upcoming Investor Conferences

Business Wire

10 months ago

enGene to Participate in Upcoming Investor Conferences

enGene Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

a year ago

enGene Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

enGene Announces Appointment of Ron Cooper as Chief Executive Officer

Business Wire

a year ago

enGene Announces Appointment of Ron Cooper as Chief Executive Officer

NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors

GlobeNewswire

a year ago

NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors

enGene Reports Second Quarter 2024 Financial Results and Provides a Business Update

Business Wire

a year ago

enGene Reports Second Quarter 2024 Financial Results and Provides a Business Update

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Should You Buy OVB Holding AG (ETR:O4B) For Its Upcoming Dividend?

Simply Wall St.

a year ago

Should You Buy OVB Holding AG (ETR:O4B) For Its Upcoming Dividend?

enGene to Present at the Jefferies Global Healthcare Conference

Business Wire

a year ago

enGene to Present at the Jefferies Global Healthcare Conference

enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors

Business Wire

a year ago

enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors

enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual Meeting

CNW Group

a year ago

enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual Meeting

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 04/23/2024

/C O R R E C T I O N -- enGene Inc./

CNW Group

a year ago

/C O R R E C T I O N -- enGene Inc./

/C O R R E C T I O N -- enGene Inc./

PR Newswire

a year ago

/C O R R E C T I O N -- enGene Inc./

enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress

PR Newswire

a year ago

enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress

enGene To Present at the Leerink Partners Global Biopharma Conference

CNW Group

a year ago

enGene To Present at the Leerink Partners Global Biopharma Conference

enGene Announces Oversubscribed $200 Million Private Placement Financing

PR Newswire

a year ago

enGene Announces Oversubscribed $200 Million Private Placement Financing

Share on Social Networks: